Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stepwise Versus Standard Antithrombotic Strategies in Patients With Atrial Fibrillation at High Thromboembolic Risk Undergoing CIED Procedures (STEP-AF Trial)

NCT07616414 is registered in ClinicalTrials.gov with Fu Wai Hospital, Beijing, China as lead sponsor.

NCT NCT07616414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07616414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stepwise Versus Standard Antithrombotic Strategies in Patients With Atrial Fibrillation at High Thromboembolic Risk Undergoing CIED Procedures (STEP-AF Trial)
Lead sponsor
Fu Wai Hospital, Beijing, China
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 26, 2026
Completion date
December 31, 2026
Enrollment
424 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac implantable electronic device, hematoma postoperative, non-valvular atrial fibrillation (nvaf), perioperative bleeding, thromboembolism